Results 11 to 20 of about 3,471 (204)

Alendronate or Alfacalcidol in Glucocorticoid-Induced Osteoporosis [PDF]

open access: yesNew England Journal of Medicine, 2006
Treatment with glucocorticoids is associated with bone loss starting soon after therapy is initiated and an increased risk of fracture.We performed a randomized, double-placebo, double-blind clinical trial of 18 months' duration among patients with a rheumatic disease who were starting glucocorticoids at a daily dose that was equivalent to at least 7.5
Nijs, R.N. de   +12 more
core   +16 more sources

Quantification of Alfacalcidol Tablets Dissolution Content by Chemical Derivatization and LC-MS

open access: yesJournal of Analytical Methods in Chemistry, 2020
Application of liquid chromatography-mass spectrometry (LC-MS) in analyzing the content of alfacalcidol tablets dissolution faces big challenges due to the low amount of alfacalcidol in each tablet and the low ionization efficacy of the compound with ...
Yang Liu   +5 more
doaj   +2 more sources

Pulse versus daily oral Alfacalcidol treatment of secondary hyperparathyroidism in hemodialysis patients: a randomized controlled trial [PDF]

open access: yesInternational Journal of Nephrology and Renovascular Disease, 2018
Osama Sawalmeh,1 Shaheed Moala,1 Zakaria Hamdan,2 Huda Masri,3 Khubaib Ayoub,4 Emad Khazneh,2 Mujahed Shraim5 1Medicine Department, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine; 2Nephrology Department ...
Sawalmeh O   +6 more
doaj   +3 more sources

Alfacalcidol in prevention and treatment of osteoporosis of endocrine genesis in children and adolescents

open access: yesЛечащий Врач, 2021
Alfacalcidol is an active synthetic preparation of vitamin D, characterized by high bioavailability and broad pharmacological properties. The article substantiates the possibility of widespread use of alfacalcidol in children and adolescents with ...
V. V. Smirnov, S. A. Miroshnichenko
doaj   +1 more source

Eleven years of experience with bisphosphonate plus alfacalcidol treatment in a man with osteogenesis imperfecta type I

open access: yesTherapeutics and Clinical Risk Management, 2012
Jun Iwamoto,1 Yoshihiro Sato,2 Mitsuyoshi Uzawa,3 Hideo Matsumoto11Institute for Integrated Sports Medicine, Keio University School of Medicine, Tokyo, 2Department of Neurology, Mitate Hospital, Fukuoka, 3Department of Orthopaedic Surgery, Keiyu ...
Iwamoto J, Sato Y, Uzawa M, Matsumoto H
doaj   +1 more source

Treatment of secondary hyperparathyroidism in haemodialysis patients: a randomised clinical trial comparing paricalcitol and alfacalcidol [PDF]

open access: yesBMC Nephrology, 2009
Background Secondary hyperparathyroidism is a common feature in patients with chronic kidney disease. Its serious clinical consequences include renal osteodystrophy, calcific uremic arteriolopathy, and vascular calcifications that increase morbidity and ...
Brandi Lisbet   +2 more
doaj   +3 more sources

Menatetrenone versus alfacalcidol in the treatment of Chinese postmenopausal women with osteoporosis: a multicenter, randomized, double-blinded, double-dummy, positive drug-controlled clinical trial

open access: yesClinical Interventions in Aging, 2014
Yan Jiang,1,* Zhen-Lin Zhang,2,* Zhong-Lan Zhang,3 Han-Min Zhu,4 Yi-Yong Wu,5 Qun Cheng,4 Feng-Li Wu,5 Xiao-Ping Xing,1 Jian-Li Liu,3 Wei Yu,6 Xun-Wu Meng11Department of Endocrinology, Key Laboratory of Endocrinology, Peking Union Medical College ...
Jiang Y   +10 more
doaj   +1 more source

Symptomatic Ferric Carboxymaltose-Induced Hypophosphataemia: A Case Series of 11 Patients. [PDF]

open access: yesEJHaem
eJHaem, Volume 7, Issue 4, August 2026.
Weerheim M   +6 more
europepmc   +2 more sources

Visible Epiglottis in an Older Adult: A Potential Indicator of Presbyphagia. [PDF]

open access: yesClin Case Rep
ABSTRACT Macroscopic visualization of the epiglottis during routine oral examination is uncommon but may suggest swallowing dysfunction in older adults. This finding may be associated with age‐related changes in tongue‐base support and may warrant further assessment of swallowing function.
Yamada M   +6 more
europepmc   +2 more sources

Three-year experience with combined treatment with alendronate and alfacalcidol in Japanese patients with severe bone loss and osteoporotic fracture

open access: yesTherapeutics and Clinical Risk Management, 2011
Jun Iwamoto1, Yoshihiro Sato2, Mitsuyoshi Uzawa3, Tsuyoshi Takeda1, Hideo Matsumoto11Institute for Integrated Sports Medicine, Keio University School of Medicine, Tokyo, Japan; 2Department of Neurology, Mitate Hospital, Fukuoka, Japan; 3Department of ...
Iwamoto J   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy